Heptavalent Pneumococcal Conjugate Vaccine
Showing 1 - 25 of 8,579
Healthy Volunteers Trial in Shijiangzhuang (15-valent pneumococcal conjugate vaccine 202210001, 15-valent pneumococcal conjugate
Recruiting
- Healthy Volunteers
- 15-valent pneumococcal conjugate vaccine 202210001
- +4 more
-
Shijiangzhuang, Hebei, ChinaHebei Provincial Center for Disease Control and Prevention
Jul 11, 2023
Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,
Recruiting
- Pneumococcal Disease
- Low dose multivalent pneumococcal conjugate vaccine formulation A
- +3 more
-
Hialeah, Florida
- +2 more
Apr 27, 2023
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine)
Not yet recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- (no location specified)
May 16, 2023
HIV, Pneumococcal Infections Trial in Puerto Rico, United States (Pneumococcal Vaccine, Polyvalent (23-valent), Pneumococcal
Completed
- HIV Infections
- Pneumococcal Infections
- Pneumococcal Vaccine, Polyvalent (23-valent)
- +2 more
-
Los Angeles, California
- +32 more
Oct 27, 2021
Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)
Not yet recruiting
- Pneumococcal Vaccines
- 12-Valent Pneumococcal Conjugate Vaccine
- (no location specified)
Jan 31, 2023
Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)
Not yet recruiting
- Pneumococcal Infection
- V116
- +3 more
- (no location specified)
Jan 13, 2023
Pneumococcal Disease Trial in India (13-valent pneumococcal conjugate vaccine)
Completed
- Pneumococcal Disease
- 13-valent pneumococcal conjugate vaccine
-
Surat, Gujarat, India
- +4 more
Jan 10, 2023
Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Recruiting
- Pneumococcal Vaccines
- 31 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Mobile, Alabama
- +24 more
Nov 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pneumococcal 13-valent Conjugate Vaccine
- Pneumococcal Polyvalent Vaccine
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 10, 2022
Pneumoccocal Immunisation Trial in United States (Pneumococcal Conjugate Vaccine - formulation 1, Pneumococcal Conjugate Vaccine
Completed
- Pneumoccocal Immunisation
- Pneumococcal Conjugate Vaccine - formulation 1
- +4 more
-
Anaheim, California
- +16 more
Aug 1, 2022
Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in
Recruiting
- Diffuse Large-Cell Lymphoma
- +3 more
- Pneumococcal conjugate vaccine (PCV13)
- CD19 targeted CAR T Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
May 31, 2022
Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection Trial in Vancouver (PCV13)
Active, not recruiting
- Invasive Pneumococcal Disease, Protection Against
- Streptococcus Pneumoniae Infection
- PCV13
-
Vancouver, British Columbia, CanadaVaccine Evaluation Center (University of BC at Children's Hospit
May 17, 2022
Pneumococcal Vaccines Trial in United States (24 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Active, not recruiting
- Pneumococcal Vaccines
- 24 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Hollywood, Florida
- +12 more
Jul 25, 2022
Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
- +3 more
-
Itoshima, Fukuoka, Japan
- +27 more
Dec 5, 2022
Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate
Active, not recruiting
- Meningococcal Infections
- MenACYW conjugate vaccine
- +5 more
-
Chlumec Nad Cidlinou, Czechia
- +30 more
Jan 4, 2023
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Not yet recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- (no location specified)
Aug 22, 2022
HIV, Hepatitis B, Measles Trial in Puerto Rico, United States (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Completed
- HIV Infections
- +4 more
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
- +4 more
-
Birmingham, Alabama
- +39 more
Oct 28, 2021
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
COVID-19, Pneumococcal Infections Trial (NVX, PCV20, Placebo)
Not yet recruiting
- COVID-19
- Pneumococcal Infections
- NVX
- +2 more
- (no location specified)
Mar 13, 2023
Rheumatoid Arthritis Trial in France, Monaco (pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine, Abatacept)
Completed
- Rheumatoid Arthritis
- pneumococcal polysaccharide vaccine
- +2 more
-
Montpellier, Hérault, France
- +10 more
Dec 30, 2021
Infants' Family Decide Baby's Vaccine Trial (Patients Decision Aids (PDA))
Not yet recruiting
- Infants' Family Decide Baby's Vaccine
- Patients Decision Aids (PDA)
- (no location specified)
Oct 10, 2022
Pneumococcal Disease Trial in Japan (V116, PPSV23)
Recruiting
- Pneumococcal Disease
- V116
- PPSV23
-
Osaka-shi, Osaka, Japan
- +7 more
Jan 18, 2023
Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against Trial in Kilifi
Active, not recruiting
- Pneumococcal Infection
- +2 more
- PCV10
- PCV13
-
Kilifi, KenyaKEMRI Wellcome Trust Research Programme
Feb 23, 2022